Literature DB >> 6726638

Use of the fluorescence probe 1-anilino-8-naphthalenesulfonate in predicting interindividual differences in the plasma protein binding of acidic drugs in rats.

J Sato, Y Sugiyama, M Hanano.   

Abstract

The possibility that the fluorescence probe, 1-anilino-8-naphthalenesulfonate (I), might be used for predicting the interindividual differences in the plasma protein binding of acidic drugs was examined. The interindividual differences in the free fraction of I (fI) were found not to be due to corresponding differences in plasma albumin concentration, but to those differences in binding constant. The binding constant of I to the plasma of 18 individual rats ranged from 1.75 X 10(6) M-1 to 2.3 X 10(7) M-1. The free fraction of I had a highly significant statistical correlation with plasma concentration of free fatty acids, but had no significant correlation with the infinite fluorescence of I or the degree of the polarization of I. Each free fraction of five acidic drugs (warfarin, phenylbutazone, salicylic acid, indomethacin, and sulfaphenazole ) was correlated with fI with high statistical significance. Therefore, the simple and convenient method using I may predict the interindividual differences in the plasma protein binding of acidic drugs in rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726638     DOI: 10.1002/jps.2600730422

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  The quaternary structure of amalgam, a Drosophila neuronal adhesion protein, explains its dual adhesion properties.

Authors:  Tzviya Zeev-Ben-Mordehai; Efstratios Mylonas; Aviv Paz; Yoav Peleg; Lilly Toker; Israel Silman; Dmitri I Svergun; Joel L Sussman
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

2.  Binding study of the fluorescence probe 1-anilino-8-naphthalensulfonate to human plasma and human and bovine serum albumin using potentiometric titration.

Authors:  G N Valsami; P E Macheras; M A Koupparis
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.